886366-43-4 Usage
Uses
Used in Pharmaceutical Synthesis:
METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-CHLORO-PHENYL)-PROPIONATE is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and functional groups allow it to participate in a range of chemical reactions, making it a valuable component in the development of new drugs.
Used in Organic Chemical Synthesis:
In the field of organic chemistry, METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-CHLORO-PHENYL)-PROPIONATE serves as a versatile building block for the synthesis of complex organic molecules. Its specific structure and functional groups enable it to be used in multiple chemical processes, contributing to the creation of a wide array of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 886366-43-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,6 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 886366-43:
(8*8)+(7*8)+(6*6)+(5*3)+(4*6)+(3*6)+(2*4)+(1*3)=224
224 % 10 = 4
So 886366-43-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H20ClNO4/c1-15(2,3)21-14(20)17-9-11(13(18)19)8-10-4-6-12(16)7-5-10/h4-7,11H,8-9H2,1-3H3,(H,17,20)(H,18,19)
886366-43-4Relevant academic research and scientific papers
PYRROLOPYRIDINES AS KINASE INHIBITORS
-
Page/Page column 47, (2009/09/04)
Compounds of Formula (I) are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.Formula, (I).
PYRAZOLOPYRIDINES AS KINASE INHIBITORS
-
Page/Page column 49, (2009/09/04)
Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
